Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer.

CONCLUSION: Compared to LMWH, rivaroxaban was associated with a higher incidence of clinically relevant bleeding in GI tract cancer patients presenting with VTE.
PMID: 31144482 [PubMed - in process]

Source: Journal of Korean Medical Science - June 1, 2019 Category: Biomedical Science Tags: J Korean Med Sci Source Type: research